Inhalers & Nebulizers
SKU
MRR-434CCDA05167
Region
Global
Publication Date
January 2024
Delivery
Immediate
2022
USD 7.48 billion
2030
USD 38.63 billion
2023
USD 9.30 billion
CAGR
22.76%
Inhalers & Nebulizers Market by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Mode - Global Forecast 2023-2030

[190 Pages Report] The Inhalers & Nebulizers Market size was estimated at USD 7.48 billion in 2022 and expected to reach USD 9.30 billion in 2023, at a CAGR 22.76% to reach USD 38.63 billion by 2030.

Inhalers & Nebulizers Market
To learn more about this report, request a free sample copy

Inhalers are compact, portable medical devices that deliver medication directly into the lungs. Inhalers come in various forms, including metered-dose inhalers (MDIs), which release a specific amount of medication in aerosol form, and dry powder inhalers (DPIs), which dispense medication in a dry powder form triggered by the patient's inhalation. Nebulizers are electronic devices that transform liquid medication into a fine mist, allowing patients to inhale the substance through a face mask or mouthpiece. Patients with respiratory diseases primarily use inhalers and nebulizers for medication administration. The increase in incidences of respiratory diseases due to pollution and smoking habits and growing awareness about the need for early diagnosis and treatment of respiratory conditions has improved the need for inhalers & nebulizers. However, the high cost of advanced inhaler technologies, the complexity of medication adherence, and patient errors in using inhaler devices correctly limit the penetration of inhalers & nebulizers. Nevertheless, the development of smart inhalers integrated with digital capabilities for monitoring usage patterns and improving compliance and the emergence of customizable options to enhance user experience is expanding the scope of the inhalers & nebulizers market worldwide.

Inhalers & Nebulizers Market - Global Forecast 2023-2030
To learn more about this report, request a free sample copy
Product: Wide availability of inhalers to overcome the respiratory disease burden

Inhalers are handheld devices that deliver medication as a mist or powder directly to the lungs. Dry powder inhalers (DPI) deliver medication as a dry, micronized powder. The patient inhales the powder deeply into the lungs through the device's mouthpiece. DPIs are often used for long-term maintenance therapy and are preferred by some patients due to their ease of use and portability. Metered dose inhalers are the commonly used inhalers and consist of a pressurized canister containing medication suspended in a propellant. When the canister is pressed down, it releases a fixed dose of the medicine in aerosol form, inhaled into the lungs. Nebulizers are medical devices used to administer medicine in the form of a mist inhaled into the lungs. Unlike inhalers, which deliver a single dose simultaneously, nebulizers can continuously deliver medication over several minutes. Jet or compressor nebulizers use compressed air to convert liquid drugs into fine mist. Jet nebulizers are commonly used in clinical and home settings but can be relatively noisy and less portable due to their size and the need for an air compressor. Mesh nebulizers are newer nebulizers that use fine mesh to produce medicinal mist. Mesh nebulizers are battery-operated and portable, making them ideal for patients who are mobile or need to administer medication while away from home. Ultrasonic nebulizers utilize high-frequency sound waves to generate vibrations that convert liquid medication into a fine mist. Ultrasonic nebulizers may not be suitable for all medications as the heat generated by the ultrasonic waves could potentially degrade certain compounds.

Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma

Asthma is a chronic lung disease indicated by the narrowing of the airways, causing shortness of breath, wheezing, chest tightness, and coughing. The choice between inhalers and nebulizers for asthma patients often depends on factors such as age, severity of asthma, ease of use, and patient preference. Chronic obstructive pulmonary disease causes airflow blockage and breathing-related problems. Treatment usually involves long-acting bronchodilators, inhaled steroids, and other medications to manage symptoms. Asthma treatment tends to involve a broader array of short-acting medications for acute management and control of symptoms. In contrast, COPD treatments focus more on long-acting medicines to manage chronic symptoms.

Regional Insights

The Americas represents a highly developing and standardized inhalers & nebulizers market due to the high prevalence of respiratory diseases, supportive government approvals, and development of novel product portfolios. Customer purchasing behavior in the Americas is strongly influenced by technological advancements and the presence of major pharmaceutical vendors investing in innovative delivery systems. Asia-Pacific’s investment in healthcare infrastructure and local pharmaceutical manufacturing fosters the growth of the inhalers & nebulizers market. A vast population and a rising incidence of respiratory conditions with an increasing trend in the use of generic drugs have expanded the scope of inhalers & nebulizers market in the Asia-Pacific. The European market is sophisticated, with stringent regulations and high penetration of advanced inhaler devices. The focus on patient compliance and ease of use drives the demand for smart and connected inhalers across the EMEA region. Africa is an emerging market with a high burden of respiratory diseases but has limited access to healthcare facilities. The increasing healthcare expenditure and desire for premium healthcare services and products are noticeable among the affluent customer segment across the EMEA region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Inhalers & Nebulizers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhalers & Nebulizers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler

    1nhaler secured funding of USD 2.5 million to propel the development of an innovative, sustainable, single-use dry powder inhaler. The Scotland-based firm aims to tackle the pressing challenges in inhalable medication delivery, namely issues of access, cost-efficiency, performance, and environmental sustainability. This inventive approach facilitates a more personalized and eco-conscious delivery of various dry powder medications, potentially revolutionizing the patient experience in drug administration. [Published On: 2023-11-27]

  • Lupin Unit Introduces Inhaler for Asthma Patients in Germany

    Lupin's subsidiary Hormosan Pharma GmbH introduced Luforbec, a sophisticated pressurized metered-dose inhaler, to the German market. This strategic move underscores Hormosan's commitment to contributing to the inhalation therapy sector and amplifies Lupin's efforts to enhance accessibility to efficient asthma and COPD treatments in Germany. [Published On: 2023-07-21]

  • Synergy Life Science Releases Nebi, a Portable Nebulizer

    Synergy Life Science, Inc. introduced Nebi, the compact, battery-operated nebulizer. This device redefines the convenience of inhalation therapy by combining portability with the clinical efficacy of traditional nebulizers. Leveraging the lungs' potent absorptive capacity, Nebi delivers medications in safe, heatless water vapor without the dangers of e-cigarettes and vape oils. [Published On: 2023-01-25]

Key Company Profiles

The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AMIKO Digital Health, AptarGroup, Inc., Beurer GmbH, Beximco Pharmaceuticals Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Dr Trust by Nureca Ltd., Drive DeVilbiss International, GF Health Products, Inc., GlaxoSmithKline PLC, H&T Presspart, ICONOVO AB, Koninklijke Philips N.V., Merck Group, Mundipharma GmbH, Narang Medical Limited, Novartis AG, Omron Corporation, PARI GmbH, Sensirion AG, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, and Vectura Group Ltd..

Market Segmentation & Coverage

This research report categorizes the Inhalers & Nebulizers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Inhalers
      • Dry Powder Inhalers
      • Metered Dose Inhalers
    • Nebulizers
      • Jet Nebulizer
      • Mesh Nebulizer
      • Ultrasonic Nebulizer
  • Indication
    • Asthma
    • COPD
  • Distribution Mode
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Inhalers & Nebulizers Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhalers & Nebulizers Market?
  3. What are the technology trends and regulatory frameworks in the Inhalers & Nebulizers Market?
  4. What is the market share of the leading vendors in the Inhalers & Nebulizers Market?
  5. Which modes and strategic moves are suitable for entering the Inhalers & Nebulizers Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageINHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. INHALERS & NEBULIZERS MARKET SIZE, 2022 VS 2030
  4. Market Overview
    1. IntroductionINHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
    2. Inhalers & Nebulizers Market, by RegionINHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsINHALERS & NEBULIZERS MARKET DYNAMICS
      1. Drivers
        1. Increasing Prevalence of Respiratory Diseases Globally
        2. Increasing Adoption of Nebulizers and Digitally-Improved Products
        3. Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
      2. Restraints
        1. Limited Availability and High Costs Associated with the Development of Smart Inhalers
      3. Opportunities
        1. Technological Advancements in Smart Inhaler Devices and Systems
        2. Growing Investment and R&D by Market Players
      4. Challenges
        1. Practical Problems Associated with Inhalers & Nebulizers
    2. Market Segmentation Analysis
      1. Product: Wide availability of inhalers to overcome the respiratory disease burden
      2. Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
    3. Market Trend Analysis
    4. Cumulative Impact of COVID-19
    5. Cumulative Impact of Russia-Ukraine Conflict
    6. Cumulative Impact of High Inflation
    7. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    8. Value Chain & Critical Path Analysis
    9. Regulatory Framework
    10. Client Customization
      1. Patent Analysis & Trend
  6. Inhalers & Nebulizers Market, by Product
    1. IntroductionINHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
    2. InhalersINHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY , 2018-2030 (USD MILLION)
    3. INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
      1. Dry Powder InhalersINHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY , 2018-2030 (USD MILLION)
      2. Metered Dose InhalersINHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY , 2018-2030 (USD MILLION)
    4. NebulizersINHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY , 2018-2030 (USD MILLION)
    5. INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
      1. Jet NebulizerINHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY , 2018-2030 (USD MILLION)
      2. Mesh NebulizerINHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY , 2018-2030 (USD MILLION)
      3. Ultrasonic NebulizerINHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY , 2018-2030 (USD MILLION)
  7. Inhalers & Nebulizers Market, by Indication
    1. IntroductionINHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
    2. AsthmaINHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY , 2018-2030 (USD MILLION)
    3. COPDINHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY , 2018-2030 (USD MILLION)
  8. Inhalers & Nebulizers Market, by Distribution Mode
    1. IntroductionINHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2022 VS 2030 (%)INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2022 VS 2023 VS 2030 (USD MILLION)INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    2. Hospital PharmaciesINHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY , 2018-2030 (USD MILLION)
    3. Online PharmaciesINHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY , 2018-2030 (USD MILLION)
    4. Retail PharmaciesINHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY , 2018-2030 (USD MILLION)
  9. Americas Inhalers & Nebulizers Market
    1. Introduction
    2. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    3. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    14. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2022 VS 2030 (%)UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Inhalers & Nebulizers Market
    1. Introduction
    2. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    6. China
    7. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    8. India
    9. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Inhalers & Nebulizers Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)POLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)POLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)QATAR INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)QATAR INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixINHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2022INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2022
    2. Market Share Analysis, By Key PlayerINHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2022INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2022
    3. Competitive Scenario Analysis, By Key Player
      1. 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler
      2. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
      3. Synergy Life Science Releases Nebi, a Portable Nebulizer
  13. Competitive Portfolio
    1. Key Company Profiles
      1. 3M Company
      2. AMIKO Digital Health
      3. AptarGroup, Inc.
      4. Beurer GmbH
      5. Beximco Pharmaceuticals Ltd.
      6. CHIESI Farmaceutici S.p.A.
      7. Cipla Limited
      8. Dr Trust by Nureca Ltd.
      9. Drive DeVilbiss International
      10. GF Health Products, Inc.
      11. GlaxoSmithKline PLC
      12. H&T Presspart
      13. ICONOVO AB
      14. Koninklijke Philips N.V.
      15. Merck Group
      16. Mundipharma GmbH
      17. Narang Medical Limited
      18. Novartis AG
      19. Omron Corporation
      20. PARI GmbH
      21. Sensirion AG
      22. Sunovion Pharmaceuticals Inc.
      23. Teva Pharmaceutical Industries Ltd.
      24. United Therapeutics Corporation
      25. Vectura Group Ltd.
    2. Key Product Portfolio
  1. 3M Company
  2. AMIKO Digital Health
  3. AptarGroup, Inc.
  4. Beurer GmbH
  5. Beximco Pharmaceuticals Ltd.
  6. CHIESI Farmaceutici S.p.A.
  7. Cipla Limited
  8. Dr Trust by Nureca Ltd.
  9. Drive DeVilbiss International
  10. GF Health Products, Inc.
  11. GlaxoSmithKline PLC
  12. H&T Presspart
  13. ICONOVO AB
  14. Koninklijke Philips N.V.
  15. Merck Group
  16. Mundipharma GmbH
  17. Narang Medical Limited
  18. Novartis AG
  19. Omron Corporation
  20. PARI GmbH
  21. Sensirion AG
  22. Sunovion Pharmaceuticals Inc.
  23. Teva Pharmaceutical Industries Ltd.
  24. United Therapeutics Corporation
  25. Vectura Group Ltd.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Inhalers & Nebulizers Market
The Global Inhalers & Nebulizers Market size was estimated at USD 7.48 billion in 2022 and expected to reach USD 9.30 billion in 2023.
The Global Inhalers & Nebulizers Market to grow USD 38.63 billion by 2030, at a CAGR of 22.76%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.